Transplant Evaluation · Listing

Listing For Liver Transplantation

Listing for a liver transplant is the final step of a detailed medical and psychosocial evaluation. Once all testing is complete, the transplant team decides whether to place a patient on the national liver transplant waiting list maintained for the United States by OPTN/UNOS. [1][6]

Liver transplant listing evaluation process

Before listing, transplant centers collect detailed medical information so the national system can prioritize those with the greatest need for a liver transplant. [1][6]

Being “listed” means that a liver transplant has been judged both medically appropriate and logistically feasible. The decision relies on national policies and expert guidelines from liver societies plus center-specific criteria. [3][4][5]

This page covers:

  • How the listing process works
  • Medical and psychosocial criteria
  • MELD and MELD exception points
  • Required tests and clearances
  • Readiness and eligibility decisions
  • How to stay active on the waiting list

Overview Of The Listing Process

Listing is the final step of the pre-transplant evaluation. After testing and consultations are complete, the multidisciplinary transplant committee decides whether to place the patient on the national waiting list in the OPTN database. [1][2][6]

  • Multidisciplinary review (hepatology, surgery, anesthesia, psychiatry, social work, cardiology)
  • Assessment of medical urgency and expected benefit from transplant
  • Check for absolute contraindications to surgery or immunosuppression
  • Verification of caregiver support, transportation, and follow-up reliability
A patient is formally “listed” only when the team agrees that transplant is indicated, the surgery is technically feasible, and the patient’s support system can safely manage the post-transplant plan.[3][5]

Medical & Psychosocial Criteria

Centers follow national policies and major society guidelines but may differ in how they apply specific criteria.[3][4]

  • End-stage liver disease or acute liver failure with poor short-term prognosis
  • Recurrent complications: ascites, variceal bleeding, hepatic encephalopathy, or liver cancer
  • No uncontrolled infection or untreatable extrahepatic malignancy
  • Stabilized or treated substance use and psychiatric conditions when present
  • Ability to understand risks, follow instructions, and attend frequent follow-up
  • Identified caregiver(s) and safe living environment after transplant
AASLD and EASL emphasize that psychosocial readiness—including adherence and support—is as important as medical urgency when deciding to list a patient. [3][4][5]

MELD & MELD Exception Points

The Model for End-Stage Liver Disease (MELD) and updated MELD 3.0 estimate the risk of death without transplant and are used to prioritize patients on the deceased donor waiting list in the U.S.[1][3][4]

  • Higher MELD score → higher predicted waitlist mortality → higher priority for offers
  • MELD 3.0 incorporates sodium and sex to improve equity for women and hyponatremic patients
  • Certain conditions may qualify for MELD exception points (e.g., hepatocellular carcinoma)
  • Exception requests are reviewed by regional or national review boards rather than individual centers
MELD is not a measure of “how well you are behaving.” It is a statistical tool designed to allocate scarce livers based on medical urgency and expected benefit. [3][4]

Required Tests For Listing

Before listing, patients undergo a comprehensive evaluation to make sure surgery and immunosuppression are as safe as possible. [3][4][5]

  • Blood tests including MELD labs (bilirubin, INR, creatinine, sodium)
  • Cross-sectional imaging (ultrasound, CT, or MRI) to evaluate liver structure and tumors
  • Cardiac testing (EKG, echocardiogram ± stress testing or catheterization when indicated)
  • Pulmonary evaluation for patients with lung disease or suspected pulmonary hypertension
  • Dental clearance to reduce the risk of post-transplant infection
  • Psychiatric and psychosocial evaluations
  • Substance use assessments and documentation of treatment or abstinence when relevant

Abnormal findings do not always mean transplant is impossible, but they may require treatment or further testing before the committee can safely approve listing. [3][5]

Readiness & Eligibility Decisions

After evaluation, the transplant selection committee typically chooses one of three options: approve, defer, or decline listing. [2][3][5]

  • Approved: patient is listed as active on the national waiting list.
  • Deferred: more tests, treatment (e.g., cardiac workup, rehab, abstinence period), or support planning are needed.
  • Declined: transplant is judged too risky or unlikely to provide benefit at this time.
OPTN policy requires that patients be notified in writing when evaluation is complete and they are either listed, deferred, or not listed, including reasons and next steps. [2]

Staying Active On The Waiting List

Listing is not permanent or automatic. Patients must meet ongoing requirements to remain “active” and eligible to receive organ offers. [1][3][4]

  • Regular MELD blood tests; frequency depends on the current score
  • Updated imaging for liver cancer surveillance when indicated
  • Documented abstinence and monitoring if alcohol or other substances were an issue
  • Ongoing management of complications such as ascites or encephalopathy
  • Prompt reporting of hospitalizations, infections, or new diagnoses

Patients can be placed temporarily “inactive” (not receiving offers) if new medical or psychosocial issues arise, then reactivated when those issues are resolved. [1][2][6]

References

  1. OPTN/UNOS – Patient Information & National Transplant Waiting List
  2. OPTN – Resources for Informing Patients About Listing Status
  3. Martin P et al. Evaluation for Liver Transplantation in Adults – AASLD/AST Guideline (Hepatology, 2014)
  4. EASL Clinical Practice Guidelines: Liver Transplantation (J Hepatol, 2016)
  5. Cleveland Clinic – Liver Transplant: Criteria, Procedure, Recovery & Outlook
  6. Columbia Surgery – Liver Transplant Waiting List Overview
Educational content — not a substitute for medical advice.
© Dr. Michael Baruch · LiverTransplantGuide.com